UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

The New England journal of medicine, 2015-01, Vol.372 (5), p.436-446

2015

Volltextzugriff (PDF)

Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss

The New England journal of medicine, 2018-06, Vol.378 (25), p.2376-2385

2018

Volltextzugriff (PDF)

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

The New England journal of medicine, 2014-07, Vol.371 (2), p.107-118

2014

Volltextzugriff (PDF)

The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model

European journal of cancer (1990), 2016-01, Vol.52, p.92-101

2016

Volltextzugriff (PDF)

Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study

Journal of clinical oncology, 2010-05, Vol.28 (15), p.2584-2590

2010

Volltextzugriff (PDF)

Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma

The New England journal of medicine, 2009-10, Vol.361 (17), p.1662-1670

2009

Volltextzugriff (PDF)

A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients

European journal of cancer (1990), 2020-12, Vol.141, p.30-39

2020

Volltextzugriff (PDF)

Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 Studies

Journal of clinical oncology, 2016-04, Vol.34 (10), p.1050-1056

2016

Volltextzugriff (PDF)

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

Breast cancer research and treatment, 2021-02, Vol.185 (3), p.697-707

2021

Volltextzugriff (PDF)

Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research

Journal of clinical oncology, 2007-08, Vol.25 (22), p.3217-3223

2007

Volltextzugriff (PDF)

The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials

Journal of Indian Association of Pediatric Surgeons, 2014-10, Vol.19 (4), p.201-207

2014

Volltextzugriff (PDF)

Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group

Pediatric blood & cancer, 2018-01, Vol.65 (1), p.n/a

2018

Volltextzugriff (PDF)

HGF/c-Met related activation of β-catenin in hepatoblastoma

Journal of experimental & clinical cancer research, 2011-10, Vol.30 (1), p.96-96, Article 96

2011

Volltextzugriff (PDF)

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

The New England journal of medicine, 2015-01, Vol.372 (5), p.436-446

2015

Volltextzugriff (PDF)

The influence of the surgeon’s and the hospital’s caseload on survival and local recurrence after colorectal cancer surgery

Surgery, 2006-03, Vol.139 (3), p.296-304

2006

Volltextzugriff (PDF)

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

The New England journal of medicine, 2018-07, Vol.379 (2), p.122-137

2018

Volltextzugriff (PDF)

CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

JNCI : Journal of the National Cancer Institute, 2012-03, Vol.104 (6), p.441-451

2012

Volltextzugriff (PDF)

Prognostic stratification for children with hepatoblastoma: The SIOPEL experience

European journal of cancer (1990), 2012-07, Vol.48 (10), p.1543-1549

2012

Volltextzugriff (PDF)

Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report

European journal of cancer (1990), 2019-01, Vol.106, p.126-132

2019

Volltextzugriff (PDF)

Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response

Hepatology (Baltimore, Md.), 2024-07, Vol.80 (1), p.55-68

2024

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Englisch
(79)
Japanisch
(13)
Deutsch
(10)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Humans
(48)
Oncology
(38)
Female
(30)
Male
(20)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Chemotherapy
(18)
Tumors
(17)
Hepatoblastoma
(15)
Middle Aged
(15)
Chemotherapy, Adjuvant
(13)
Child
(13)
Treatment Outcome
(13)
Aged
(12)
Breast Neoplasms - Drug Therapy
(12)
Adolescent
(11)
Adult
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss

Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model

Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study

Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study

Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma

A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients

Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 Studies

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials

Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group

Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children's Hepatic Tumors International Collaboration (CHIC)

HGF/c-Met related activation of β-catenin in hepatoblastoma

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

The influence of the surgeon’s and the hospital’s caseload on survival and local recurrence after colorectal cancer surgery

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

Prognostic stratification for children with hepatoblastoma: The SIOPEL experience

Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report

Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response

Suchergebnisse filtern